MoneyWorks4Me

Biocon raises Rs 600 crore through commercial papers

23 Apr 2025 Evaluate

Biocon has raised Rs 600 crore through Commercial Papers (CPs) on private placement basis. Maturity of the said Commercial Papers will be on September 30, 2025. 

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. 

Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..